Latest updates for Vedtx

Fresh curated links around VEDTX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • VTEB: Simple Municipal Bond Index ETF, Weak Investment Thesis, Better Choices Out There
  • Vertical Data Inc. Begins Trading on the OTCQB Venture Market Under Ticker Symbol "VDTA"
  • VBR: Leading Passive Small Value ETF

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /1 month ago

VTEB: Simple Municipal Bond Index ETF, Weak Investment Thesis, Better Choices Out There

Read source
newswire.com /1 month ago

Vertical Data Inc. Begins Trading on the OTCQB Venture Market Under Ticker Symbol "VDTA"

Public Markets Access Accelerates Capital Deployment for Vertical Data's AI Infrastructure Expansion

Read source
seekingalpha.com /1 month ago

VBR: Leading Passive Small Value ETF

Read source
seekingalpha.com /1 month ago

VTV: Vanguard's Passive $169B Value ETF Is Good, But SEIV's Active Approach May Be Better

Read source
fool.com /1 week ago

Crafting title options within editorial guidelines An ETF Shop Just Made a Beaten-Down Medtech Its Top Holding

Artivion delivers advanced cardiovascular and vascular solutions to healthcare providers worldwide through its proprietary medical devices.

Read source
seekingalpha.com /3 weeks ago

Vertex Pharmaceuticals Incorporated (VRTX) Q1 2026 Earnings Call Transcript

Read source
seekingalpha.com /1 month ago

Small-cap healthcare stocks with A+ grade EPS revisions ahead of earnings

Read source
fool.com /1 week ago

Pennington Partners Bets Big on Broad Market With $5.4 Million VTHR Buy

The Vanguard Russell 3000 ETF offers investors a single-fund solution for diversified exposure to nearly the entire U.S. equity market through a low-cost, passively managed strateg...

Read source
fool.com /1 week ago

Pennington Partners Bets Big on Broad Market With $5.4 Million VTHR Buy

The Vanguard Russell 3000 ETF offers investors a single-fund solution for diversified exposure to nearly the entire U.S. equity market through a low-cost, passively managed strateg...

Read source
seekingalpha.com /4 weeks ago

Vaxcyte's Manufacturing-Backed Vaccine Platform Is Redefining The PCV Market

Read source
seekingalpha.com /3 weeks ago

EVERTEC, Inc. 2026 Q1 - Results - Earnings Call Presentation

Read source
seekingalpha.com /3 weeks ago

Vaxart anticipates early 2027 primary efficacy readout while aiming for Q2 sentinel data release

Read source
finance.yahoo.com /1 month ago

Truist Reiterates Buy Rating for Viridian Therapeutics (VRDN)

Read source
fool.com /1 week ago

This Biotech Has a June 30 FDA Catalyst. A Fund Just Cut Its Stake by $7 Million

Viridian Therapeutics develops monoclonal antibody therapies targeting serious diseases, with a primary focus on thyroid eye disease.

Read source
fool.com /1 month ago

1 No-Brainer Healthcare Vanguard ETF to Buy Right Now for Less Than $1,000

Healthcare stocks have been laggards for a while now. The current economic slowdown and structural tailwinds make it much more attractive now.

Read source
seekingalpha.com /1 month ago

Definium Therapeutics, Inc. (DFTX) Analyst/Investor Day - Slideshow

Read source
seekingalpha.com /1 month ago

VAT Group AG (VACNY) Q1 2026 Sales/Trading Call Transcript

Read source
seekingalpha.com /1 month ago

TDVG ETF: Quietly Holding Up Amidst Market Chaos

Read source
finance.yahoo.com /1 month ago

Mar Vista U.S. Quality Strategy Exited Veralto Corporation (VLTO) for More Compelling Opportunities

Read source
fool.com /1 month ago

The Best Vanguard ETF to Invest $1,000 in This April

With the markets looking very choppy so far in 2026, this sector has the tailwinds to keep moving higher.

Read source
finance.yahoo.com /1 month ago

Travere Therapeutics Inc. (TVTX): First-Mover Advantage Is Massive Moat

Read source
seekingalpha.com /1 month ago

Solventum: A Hidden Breakup Story In Healthcare

Read source
seekingalpha.com /1 month ago

Large-cap IT stocks with A+ grade EPS revisions as earnings season begins

Read source
seekingalpha.com /2 weeks ago

Tech's Spectacular Superlatives

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Vedtx

seekingalpha.com

Recent coverage from public sources
Public source

finance.yahoo.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

fool.com

Recent coverage from public sources
Public source

newswire.com

Recent coverage from public sources
Public source